INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 446s ago
HOUSE PTR24s ago
SEC 13F16s ago
ROBINHOOD CHAIN12s ago
PJ
Corporate insider

Perl Jessica

SVP, General Counsel, Corp SecCIK 0002043716

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score21
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
PJ
Perl JessicaSVP, General Counsel, Corp Sec
EBSEmergent BioSolutions Inc.
Grant or award
A—
104.3K sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Emergent BioSolutions Inc.SVP, General Counsel, Corp Sec · Feb 10, 2026
17
PJ
Perl JessicaSVP, General Counsel, Corp Sec
EBSEmergent BioSolutions Inc.
Grant or award
A
—
46.7K sh
Mar 3, 2026
Mar 5, 2026
traded Mar 3, 2026
+2d
SEC FORM 4

Evidence

16
PJ
Perl JessicaSVP, General Counsel, Corp Sec
EBSEmergent BioSolutions Inc.
Tax withholding
F$55K
6,465 sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC FORM 4

Evidence

9
PJ
Perl JessicaSVP, General Counsel, Corp Sec
EBSEmergent BioSolutions Inc.
Tax withholding
F$10K
918 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC FORM 4

Evidence